Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants
Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants
Business Wire – 3 hours ago
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a …
Idera Pharma (IDRA) Extends TLR Research Collaboration with Merck (MRK) – StreetInsider.com
Idera Says Merck Extends Research Collaboration To Fourth Year; Ends Asthma, Allergy Research With Novartis – Update – RTT News
Mass High Tech
Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .